Haemonetics Stock Surges 17% on CSL Plasma Deal Haemonetics Stock Surges 17% as CSL Plasma Revives U.S. Supply Deal Haemonetics (NYSE: HAE) shares jumped more than 17% in August after th... October 08, 2026 Read Guide →
